Cargando…
Epithelial Protein Lost in Neoplasm, EPLIN, the Cellular and Molecular Prospects in Cancers
Epithelial Protein Lost In Neoplasm (EPLIN), also known as LIMA1 (LIM Domain And Actin Binding 1), was first discovered as a protein differentially expressed in normal and cancerous cell lines. It is now known to be key to the progression and metastasis of certain solid tumours. Despite a slow pace...
Autores principales: | Zeng, Jianyuan, Jiang, Wen G., Sanders, Andrew J. |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
MDPI
2021
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8301816/ https://www.ncbi.nlm.nih.gov/pubmed/34356662 http://dx.doi.org/10.3390/biom11071038 |
Ejemplares similares
-
Epithelial protein lost in neoplasm (EPLIN): Beyond a tumor suppressor
por: Wu, Daqing
Publicado: (2017) -
EPLIN Expression in Gastric Cancer and Impact on Prognosis and Chemoresistance
por: Gong, Wenjing, et al.
Publicado: (2021) -
Epithelial Protein Lost in Neoplasm α (Eplin-α) is transcriptionally regulated by G-actin and MAL/MRTF coactivators
por: Leitner, Laura, et al.
Publicado: (2010) -
EPLIN, a Putative Tumour Suppressor in Colorectal Cancer, Implications in Drug Resistance
por: Zeng, Jianyuan, et al.
Publicado: (2022) -
EPLIN: a fundamental actin regulator in cancer metastasis?
por: Collins, Ross J., et al.
Publicado: (2015)